<p>Mutant polypeptides of the present invention contain an Fc region in which a cysteine residue is substituted for the second amino acid from the glycosylation site to the N terminal side in the Fc region. The Fc region is preferably a human IgG Fc region. The mutant polypeptides of the present invention may also contain an N-linked sugar chain at the glycosylation site in Fc region. Furthermore, a polypeptide domain other than the Fc region of the mutant polypeptides of the present invention may be a polypeptide molecule that recognizes a human cell surface molecule.</p>
申请公布号
EP2011870(A1)
申请公布日期
2009.01.07
申请号
EP20070741539
申请日期
2007.04.12
申请人
MEDICAL AND BIOLOGICAL LABORATORIES CO., LTD.;OTSUKA CHEMICAL CO., LTD.